If nausea persists during dose increases, your healthcare provider might adjust your plan by extending the current dose for an additional 2-4 weeks, pausing further increases until symptoms improve, or temporarily lowering the dose
CXCR4 antagonism attenuates the development of diabetic cardiac fibrosis
Cardiovascular exercise provides additional calorie burning and cardiovascular health benefits but does relatively little for muscle preservation compared to resistance training
In a clinical trial, Grigson and her colleagues tested the safety and efficacy of daily injections of a GLP-1 receptor agonist, liraglutide, in people receiving treatment for opioid use disorder
Miao, X
Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ